nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Remifentanil—Somnolence—Gemcitabine—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Remifentanil—Hypokalaemia—Epirubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Remifentanil—Paraesthesia—Fluorouracil—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Remifentanil—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Remifentanil—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Remifentanil—Somnolence—Fluorouracil—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Remifentanil—Hypotension—Cisplatin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Remifentanil—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Remifentanil—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Remifentanil—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Remifentanil—Confusional state—Etoposide—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Remifentanil—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Remifentanil—Pain—Gemcitabine—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Remifentanil—Constipation—Gemcitabine—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Remifentanil—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Remifentanil—Dysphagia—Epirubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Remifentanil—Dysuria—Methotrexate—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Remifentanil—Pruritus—Thiotepa—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Remifentanil—Pain—Fluorouracil—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Remifentanil—Paraesthesia—Cisplatin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Remifentanil—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Remifentanil—Tachycardia—Etoposide—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Remifentanil—Dyspnoea—Cisplatin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Remifentanil—Skin disorder—Etoposide—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Remifentanil—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Remifentanil—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Remifentanil—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Remifentanil—Diarrhoea—Thiotepa—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Remifentanil—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Remifentanil—Bronchitis—Epirubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Remifentanil—Pneumonia—Methotrexate—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Remifentanil—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Remifentanil—Hypotension—Etoposide—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Remifentanil—Pain—Cisplatin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Remifentanil—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Remifentanil—Renal failure—Methotrexate—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Remifentanil—Dysuria—Epirubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Remifentanil—Dizziness—Thiotepa—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Remifentanil—Urticaria—Fluorouracil—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Remifentanil—Dysphagia—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Remifentanil—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Remifentanil—Sweating—Methotrexate—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Remifentanil—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Remifentanil—Paraesthesia—Etoposide—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Remifentanil—Haematuria—Methotrexate—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Dyspnoea—Etoposide—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Remifentanil—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Remifentanil—Somnolence—Etoposide—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Remifentanil—Vomiting—Thiotepa—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Remifentanil—Pneumonia—Epirubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Remifentanil—Rash—Thiotepa—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Remifentanil—Bronchitis—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Remifentanil—Dermatitis—Thiotepa—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Remifentanil—Headache—Thiotepa—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Remifentanil—Renal failure—Epirubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Remifentanil—Body temperature increased—Cisplatin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Remifentanil—Pain—Etoposide—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Remifentanil—Constipation—Etoposide—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Remifentanil—Dysuria—Doxorubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Remifentanil—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Remifentanil—Haemoglobin—Methotrexate—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Remifentanil—Haemorrhage—Methotrexate—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Remifentanil—Sweating—Epirubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Remifentanil—Haematuria—Epirubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Remifentanil—Pharyngitis—Methotrexate—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Remifentanil—Pruritus—Gemcitabine—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Remifentanil—Nausea—Thiotepa—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Remifentanil—Feeling abnormal—Etoposide—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Remifentanil—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Remifentanil—Pneumonia—Doxorubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Remifentanil—Pruritus—Fluorouracil—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Remifentanil—Visual impairment—Methotrexate—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Remifentanil—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Remifentanil—Bradycardia—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Remifentanil—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Remifentanil—Renal failure—Doxorubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Remifentanil—Urticaria—Etoposide—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Remifentanil—Haemoglobin—Epirubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Remifentanil—Body temperature increased—Etoposide—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Remifentanil—Haemorrhage—Epirubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Remifentanil—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Remifentanil—Pharyngitis—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Remifentanil—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Remifentanil—Angiopathy—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Remifentanil—Immune system disorder—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Remifentanil—Dizziness—Fluorouracil—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Remifentanil—Visual impairment—Epirubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Remifentanil—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Remifentanil—Chills—Methotrexate—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Remifentanil—Diarrhoea—Cisplatin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Remifentanil—Vomiting—Gemcitabine—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Remifentanil—Rash—Gemcitabine—urinary bladder cancer	0.000999	0.000999	CcSEcCtD
Remifentanil—Dermatitis—Gemcitabine—urinary bladder cancer	0.000998	0.000998	CcSEcCtD
Remifentanil—Hypersensitivity—Etoposide—urinary bladder cancer	0.000997	0.000997	CcSEcCtD
Remifentanil—Erythema—Methotrexate—urinary bladder cancer	0.000993	0.000993	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000993	0.000993	CcSEcCtD
Remifentanil—Headache—Gemcitabine—urinary bladder cancer	0.000993	0.000993	CcSEcCtD
Remifentanil—Flushing—Epirubicin—urinary bladder cancer	0.000991	0.000991	CcSEcCtD
Remifentanil—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000991	0.000991	CcSEcCtD
Remifentanil—Vomiting—Fluorouracil—urinary bladder cancer	0.000991	0.000991	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000988	0.000988	CcSEcCtD
Remifentanil—Rash—Fluorouracil—urinary bladder cancer	0.000982	0.000982	CcSEcCtD
Remifentanil—Dermatitis—Fluorouracil—urinary bladder cancer	0.000981	0.000981	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00098	0.00098	CcSEcCtD
Remifentanil—Headache—Fluorouracil—urinary bladder cancer	0.000976	0.000976	CcSEcCtD
Remifentanil—Angiopathy—Epirubicin—urinary bladder cancer	0.000969	0.000969	CcSEcCtD
Remifentanil—Immune system disorder—Epirubicin—urinary bladder cancer	0.000964	0.000964	CcSEcCtD
Remifentanil—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000962	0.000962	CcSEcCtD
Remifentanil—Chills—Epirubicin—urinary bladder cancer	0.000958	0.000958	CcSEcCtD
Remifentanil—Pruritus—Etoposide—urinary bladder cancer	0.000957	0.000957	CcSEcCtD
Remifentanil—Arrhythmia—Epirubicin—urinary bladder cancer	0.000954	0.000954	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—urinary bladder cancer	0.000952	0.000952	CcSEcCtD
Remifentanil—Nausea—Gemcitabine—urinary bladder cancer	0.000941	0.000941	CcSEcCtD
Remifentanil—Vomiting—Cisplatin—urinary bladder cancer	0.000939	0.000939	CcSEcCtD
Remifentanil—Rash—Cisplatin—urinary bladder cancer	0.000931	0.000931	CcSEcCtD
Remifentanil—Dermatitis—Cisplatin—urinary bladder cancer	0.00093	0.00093	CcSEcCtD
Remifentanil—Erythema—Epirubicin—urinary bladder cancer	0.000929	0.000929	CcSEcCtD
Remifentanil—Diarrhoea—Etoposide—urinary bladder cancer	0.000926	0.000926	CcSEcCtD
Remifentanil—Nausea—Fluorouracil—urinary bladder cancer	0.000925	0.000925	CcSEcCtD
Remifentanil—Anaemia—Methotrexate—urinary bladder cancer	0.000918	0.000918	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—urinary bladder cancer	0.000917	0.000917	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000917	0.000917	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—urinary bladder cancer	0.000896	0.000896	CcSEcCtD
Remifentanil—Dizziness—Etoposide—urinary bladder cancer	0.000895	0.000895	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000892	0.000892	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00089	0.00089	CcSEcCtD
Remifentanil—Chills—Doxorubicin—urinary bladder cancer	0.000886	0.000886	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000882	0.000882	CcSEcCtD
Remifentanil—Nausea—Cisplatin—urinary bladder cancer	0.000877	0.000877	CcSEcCtD
Remifentanil—Cough—Methotrexate—urinary bladder cancer	0.000867	0.000867	CcSEcCtD
Remifentanil—Convulsion—Methotrexate—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Remifentanil—Vomiting—Etoposide—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Remifentanil—Anaemia—Epirubicin—urinary bladder cancer	0.000859	0.000859	CcSEcCtD
Remifentanil—Agitation—Epirubicin—urinary bladder cancer	0.000854	0.000854	CcSEcCtD
Remifentanil—Rash—Etoposide—urinary bladder cancer	0.000853	0.000853	CcSEcCtD
Remifentanil—Dermatitis—Etoposide—urinary bladder cancer	0.000852	0.000852	CcSEcCtD
Remifentanil—Headache—Etoposide—urinary bladder cancer	0.000848	0.000848	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00084	0.00084	CcSEcCtD
Remifentanil—Syncope—Epirubicin—urinary bladder cancer	0.000833	0.000833	CcSEcCtD
Remifentanil—Confusional state—Methotrexate—urinary bladder cancer	0.000817	0.000817	CcSEcCtD
Remifentanil—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000817	0.000817	CcSEcCtD
Remifentanil—Cough—Epirubicin—urinary bladder cancer	0.000811	0.000811	CcSEcCtD
Remifentanil—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00081	0.00081	CcSEcCtD
Remifentanil—Convulsion—Epirubicin—urinary bladder cancer	0.000805	0.000805	CcSEcCtD
Remifentanil—Nausea—Etoposide—urinary bladder cancer	0.000804	0.000804	CcSEcCtD
Remifentanil—Hypertension—Epirubicin—urinary bladder cancer	0.000802	0.000802	CcSEcCtD
Remifentanil—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000795	0.000795	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—urinary bladder cancer	0.000795	0.000795	CcSEcCtD
Remifentanil—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000794	0.000794	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—urinary bladder cancer	0.00079	0.00079	CcSEcCtD
Remifentanil—Anxiety—Epirubicin—urinary bladder cancer	0.000788	0.000788	CcSEcCtD
Remifentanil—Skin disorder—Methotrexate—urinary bladder cancer	0.000787	0.000787	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000786	0.000786	CcSEcCtD
Remifentanil—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000784	0.000784	CcSEcCtD
Remifentanil—Dry mouth—Epirubicin—urinary bladder cancer	0.000774	0.000774	CcSEcCtD
Remifentanil—Syncope—Doxorubicin—urinary bladder cancer	0.000771	0.000771	CcSEcCtD
Remifentanil—Confusional state—Epirubicin—urinary bladder cancer	0.000765	0.000765	CcSEcCtD
Remifentanil—Oedema—Epirubicin—urinary bladder cancer	0.000758	0.000758	CcSEcCtD
Remifentanil—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000758	0.000758	CcSEcCtD
Remifentanil—Hypotension—Methotrexate—urinary bladder cancer	0.000757	0.000757	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000756	0.000756	CcSEcCtD
Remifentanil—Cough—Doxorubicin—urinary bladder cancer	0.00075	0.00075	CcSEcCtD
Remifentanil—Shock—Epirubicin—urinary bladder cancer	0.000746	0.000746	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—urinary bladder cancer	0.000745	0.000745	CcSEcCtD
Remifentanil—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000744	0.000744	CcSEcCtD
Remifentanil—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000743	0.000743	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—urinary bladder cancer	0.000742	0.000742	CcSEcCtD
Remifentanil—Tachycardia—Epirubicin—urinary bladder cancer	0.00074	0.00074	CcSEcCtD
Remifentanil—Skin disorder—Epirubicin—urinary bladder cancer	0.000737	0.000737	CcSEcCtD
Remifentanil—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000733	0.000733	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—urinary bladder cancer	0.00073	0.00073	CcSEcCtD
Remifentanil—Paraesthesia—Methotrexate—urinary bladder cancer	0.000728	0.000728	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000727	0.000727	CcSEcCtD
Remifentanil—Dyspnoea—Methotrexate—urinary bladder cancer	0.000723	0.000723	CcSEcCtD
Remifentanil—Somnolence—Methotrexate—urinary bladder cancer	0.000721	0.000721	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—urinary bladder cancer	0.000716	0.000716	CcSEcCtD
Remifentanil—Dyspepsia—Methotrexate—urinary bladder cancer	0.000713	0.000713	CcSEcCtD
Remifentanil—Hypotension—Epirubicin—urinary bladder cancer	0.000709	0.000709	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—urinary bladder cancer	0.000708	0.000708	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—urinary bladder cancer	0.000702	0.000702	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000702	0.000702	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.0007	0.0007	CcSEcCtD
Remifentanil—Pain—Methotrexate—urinary bladder cancer	0.000693	0.000693	CcSEcCtD
Remifentanil—Shock—Doxorubicin—urinary bladder cancer	0.00069	0.00069	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000688	0.000688	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000687	0.000687	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—urinary bladder cancer	0.000685	0.000685	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—urinary bladder cancer	0.000682	0.000682	CcSEcCtD
Remifentanil—Paraesthesia—Epirubicin—urinary bladder cancer	0.000681	0.000681	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000678	0.000678	CcSEcCtD
Remifentanil—Dyspnoea—Epirubicin—urinary bladder cancer	0.000676	0.000676	CcSEcCtD
Remifentanil—Somnolence—Epirubicin—urinary bladder cancer	0.000674	0.000674	CcSEcCtD
Remifentanil—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000668	0.000668	CcSEcCtD
Remifentanil—Dyspepsia—Epirubicin—urinary bladder cancer	0.000668	0.000668	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—urinary bladder cancer	0.000656	0.000656	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000655	0.000655	CcSEcCtD
Remifentanil—Pain—Epirubicin—urinary bladder cancer	0.000649	0.000649	CcSEcCtD
Remifentanil—Constipation—Epirubicin—urinary bladder cancer	0.000649	0.000649	CcSEcCtD
Remifentanil—Urticaria—Methotrexate—urinary bladder cancer	0.000644	0.000644	CcSEcCtD
Remifentanil—Body temperature increased—Methotrexate—urinary bladder cancer	0.000641	0.000641	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00063	0.00063	CcSEcCtD
Remifentanil—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000626	0.000626	CcSEcCtD
Remifentanil—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000625	0.000625	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—urinary bladder cancer	0.000624	0.000624	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000618	0.000618	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000606	0.000606	CcSEcCtD
Remifentanil—Urticaria—Epirubicin—urinary bladder cancer	0.000603	0.000603	CcSEcCtD
Remifentanil—Pain—Doxorubicin—urinary bladder cancer	0.0006	0.0006	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—urinary bladder cancer	0.0006	0.0006	CcSEcCtD
Remifentanil—Body temperature increased—Epirubicin—urinary bladder cancer	0.0006	0.0006	CcSEcCtD
Remifentanil—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000597	0.000597	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000578	0.000578	CcSEcCtD
Remifentanil—Pruritus—Methotrexate—urinary bladder cancer	0.000573	0.000573	CcSEcCtD
Remifentanil—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000559	0.000559	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—urinary bladder cancer	0.000558	0.000558	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000555	0.000555	CcSEcCtD
Remifentanil—Diarrhoea—Methotrexate—urinary bladder cancer	0.000555	0.000555	CcSEcCtD
Remifentanil—Pruritus—Epirubicin—urinary bladder cancer	0.000537	0.000537	CcSEcCtD
Remifentanil—Dizziness—Methotrexate—urinary bladder cancer	0.000536	0.000536	CcSEcCtD
Remifentanil—Diarrhoea—Epirubicin—urinary bladder cancer	0.000519	0.000519	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000517	0.000517	CcSEcCtD
Remifentanil—Vomiting—Methotrexate—urinary bladder cancer	0.000515	0.000515	CcSEcCtD
Remifentanil—Rash—Methotrexate—urinary bladder cancer	0.000511	0.000511	CcSEcCtD
Remifentanil—Dermatitis—Methotrexate—urinary bladder cancer	0.000511	0.000511	CcSEcCtD
Remifentanil—Headache—Methotrexate—urinary bladder cancer	0.000508	0.000508	CcSEcCtD
Remifentanil—Dizziness—Epirubicin—urinary bladder cancer	0.000502	0.000502	CcSEcCtD
Remifentanil—Pruritus—Doxorubicin—urinary bladder cancer	0.000497	0.000497	CcSEcCtD
Remifentanil—Vomiting—Epirubicin—urinary bladder cancer	0.000482	0.000482	CcSEcCtD
Remifentanil—Nausea—Methotrexate—urinary bladder cancer	0.000481	0.000481	CcSEcCtD
Remifentanil—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00048	0.00048	CcSEcCtD
Remifentanil—Rash—Epirubicin—urinary bladder cancer	0.000478	0.000478	CcSEcCtD
Remifentanil—Dermatitis—Epirubicin—urinary bladder cancer	0.000478	0.000478	CcSEcCtD
Remifentanil—Headache—Epirubicin—urinary bladder cancer	0.000475	0.000475	CcSEcCtD
Remifentanil—Dizziness—Doxorubicin—urinary bladder cancer	0.000464	0.000464	CcSEcCtD
Remifentanil—Nausea—Epirubicin—urinary bladder cancer	0.000451	0.000451	CcSEcCtD
Remifentanil—Vomiting—Doxorubicin—urinary bladder cancer	0.000446	0.000446	CcSEcCtD
Remifentanil—Rash—Doxorubicin—urinary bladder cancer	0.000443	0.000443	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—urinary bladder cancer	0.000442	0.000442	CcSEcCtD
Remifentanil—Headache—Doxorubicin—urinary bladder cancer	0.00044	0.00044	CcSEcCtD
Remifentanil—Nausea—Doxorubicin—urinary bladder cancer	0.000417	0.000417	CcSEcCtD
